Effects of Cardiomyopathic Mutations on the Cytoplasmic Tropomyosin Isoform Tpm1.7
Molecules · 22.05.2026 · 31 (11) · 1784
DOI: 10.3390/molecules31111784 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 22.05.2026. Verfasst von Svetlana G Roman und 9 weiteren Autor:innen. Beteiligte Einrichtung: Research Centre of Biotechnology, Russian Academy of Sciences, 119071 Moscow, Russia. Hauptthemen laut MEDLINE: Tropomyosin, Cardiomyopathies, Mutation, Cytoplasm. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
Tropomyosins (Tpm) are the family of actin-binding proteins encoded by four genes in humans. Missense mutations in the TPM1 gene associated with cardiomyopathies have been studied in the sarcomeric isoform Tpm1.1. The cardiomyopathy-causing mutations E40K and E54K are located in exon 2b of the TPM1 gene and may be expressed in non-muscle cytoplasmic Tpm isoforms, including Tpm1.7, which is associated with early tissue development. In the present work, we investigate the effects of mutations E40K and E54K on the properties of Tpm1.7. The E40K and E54K mutations caused destabilization of the Tpm1.7 molecule at the N- and C-termini parts. Neither mutation affected the Tpm1.7 affinity for filamentous actin (F-actin). The bending stiffness of F-actin/Tpm1.7 E40K filaments was lower compared to F-actin/Tpm1.7 WT (wild-type). The interplay of Tpm1.7 and motor proteins was studied in an in vitro motility assay with skeletal myosin. Tpm1.7 WT reduced the sliding velocity of F-actin by half; the velocity of F-actin with Tpm1.7 E54K did not differ from that of bare F-actin; and Tpm1.7 E40K decreased the F-actin velocity by approximately threefold. While Tpm1.7 E40K did not affect the protective effect of Tpm1.7 against F-actin severing by cofilin-1, the E54K mutation enhanced protection against cofilin-1. Thus, cardiomyopathic mutations in the TPM1 gene can affect the properties of non-muscle Tpm isoforms, which indicates that this should be taken into account when studying the molecular mechanisms of the pathogenesis of these diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Centre of Biotechnology, Russian Academy of Sciences, 119071 Moscow, Russia.
- Institute of Immunology and Physiology, Ural Branch of Russian Academy of Sciences, 620049 Yekaterinburg, Russia.
- Koltzov Institute of Developmental Biology, Russian Academy of Sciences, 119334 Moscow, Russia.
ORCID-Profile: Svetlana G Roman, Salavat R Nabiev, Anastasia M Kochurova, Galina V Kopylova, Julia Y Antonets, Sergey Y Kleymenov, Valeriya V Mikhaylova, Daniil V Shchepkin, Alexander M Matyushenko
Förderung
- Russian Science Foundation
Zitieren
APA
Roman, S. G., Nabiev, S. R., Kochurova, A. M., Kopylova, G. V., Antonets, J. Y., Kleymenov, S. Y., Mikhaylova, V. V., Shchepkin, D. V., Matyushenko, A. M., & Nefedova, V. V. (2026). Effects of Cardiomyopathic Mutations on the Cytoplasmic Tropomyosin Isoform Tpm1.7. Molecules, 31(11), 1784. https://doi.org/10.3390/molecules31111784
Vancouver
Roman SG, Nabiev SR, Kochurova AM, Kopylova GV, Antonets JY, Kleymenov SY, et al. Effects of Cardiomyopathic Mutations on the Cytoplasmic Tropomyosin Isoform Tpm1.7. Molecules. 2026;31(11):1784. doi:10.3390/molecules31111784
BibTeX
@article{Roman2026,
author = {Roman, Svetlana G and Nabiev, Salavat R and Kochurova, Anastasia M and Kopylova, Galina V and Antonets, Julia Y and Kleymenov, Sergey Y and Mikhaylova, Valeriya V and Shchepkin, Daniil V and Matyushenko, Alexander M and Nefedova, Victoria V},
title = {Effects of Cardiomyopathic Mutations on the Cytoplasmic Tropomyosin Isoform Tpm1.7},
journal = {Molecules},
year = {2026},
volume = {31},
number = {11},
pages = {1784},
doi = {10.3390/molecules31111784}
}
EUVIMED